FDA May Convene Covid-19 Vaccine Panel on October 22

The Food and Drug Administration is tentatively planning an advisory panel to meet Oct. 22 to discuss a Covid-19 vaccine, the agency’s deputy commissioner for medical and scientific affairs Anand Shah said. Shah did not specify which vaccines, or how many, may be scrutinized at the meeting.

• The committee may also be bolstered by scientific experts on the novel coronavirus, Shah said on a call with reporters
  • Investors have been trying to handicap when a vaccine may receive a regulatory nod, with some arguing that an authorization could come prior to the Nov. 4 U.S. general election
  • Companies leading the ...